MedPath

sciatica treatment through venous blood letting from leg vessels.

Phase 2
Not yet recruiting
Conditions
Sciatica,
Registration Number
CTRI/2021/02/031581
Lead Sponsor
National Institute of Unani Medicine NIUM
Brief Summary

Sciatica refers to pain or discomfort associated with sciatic nerve. Injury to or pressure on the sciatic nerve can cause the characteristic pain of sciatica: a sharp or burning pain that radiates from the lower back or hip, possibly following the path of the sciatic nerve to the foot. It is one of the commonest neuralgic pain creating difficulty and problems in activities of daily living. The overall incidence of this condition is approximately between 13- 40 % and the malady has the potential to become chronic and intractable with major socioeconomic implication.Sciatica is usually treated by the conventional therapies either pharmacologically or surgically or sometimes, both. these therapies are associated with certain side effects and complications; therefore, search for a safe and effective regimen is the need of the hour. There is a disease in Unani system of medicine known as **‘***IrqunnasÄ* its signs and symptoms mimick almost completely with sciatica. Hence, any approach for treating **‘***IrqunnasÄ* will also be beneficial for sciatica. For **‘***IrqunnasÄ* there are a no. of different kinds of regimens given  which are more effective with less adverse effects and at the same time cost effective like *HÌ£ijÄma* (Cupping), *IrsÄl-i-‘Alaq* (Leech therapy), *Dalk* (massage), *Ä€bzan* (Sitz Bath) and  *FasÌ£d* (Venesection). Almost all great Unani physicians advocated *FasÌ£d* in the treatment of **‘***IrqunnasÄ* . Therefore, it is high time to evaluate the efficacy and safety of *FasÌ£d* in the  management  of **‘***IrqunnasÄ*.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Clinically diagnosed cases of ‘IrqunnasÄ (SLR 30-70ï‚°)15 2.Pain in the range of 4 to 9 on VAS.
  • 3.Both genders 4.Patients between 20 to 55 years of age 5.Hb13gm/dl or more 6.Patients willing to take part in the study.
Exclusion Criteria

1.who fail to give consent for the trial and follow up 2.Pregnancy, Lactation 3.Systemic illness e.g. cancer, liver, kidney, cardiac and pulmonary diseases 4.Bleeding tendencies 5.Hypotension (Below 100/60mmHg) 6.Spinal injury or deformity (Congenital / Acquired) 7.Any orthopedic condition of hip joint restricting gait and movement 8.Patients Positive cases of HIV or HBsAg.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1Straight Leg Raising Test14th day | 28th day
2VAS (visual analogue scale)14th day | 28th day
Secondary Outcome Measures
NameTimeMethod
1ODI (Oswestry Disability Index)162SBI (Sciatica Bothersomeness Index)

Trial Locations

Locations (1)

Hospital National Institute of Unani Medicine

🇮🇳

Bangalore, KARNATAKA, India

Hospital National Institute of Unani Medicine
🇮🇳Bangalore, KARNATAKA, India
Dr Abdul Azeez
Principal investigator
8618858677
aafaris@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.